Novellia raises $18M to scale patient-controlled medical data platform
Patient-controlled health data startup Novellia Inc. today announced it has raised $18 million in Series A funding to scale up a platform that lets patients consolidate their medical records and choose to share them with drug companies for research.
The company also announced the launch of a patient-facing mobile app.
Novellia operates what it calls the only real-world data company built entirely on information patients elect to contribute, positioning itself against third-party data brokers that assemble research datasets from insurance claims and hospital records. It says the current model leaves the patient out of the equation despite a market that runs above $50 billion a year.
Novellia’s platform pulls together as much as 20 years of medical history from disparate hospital systems, doctors’ offices and labs across the U.S. in under 30 seconds. The company says the tool is particularly aimed at people managing serious or complex conditions, who typically spend hours chasing down records and repeating their histories to new providers.
